HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells.

Abstract
Granulocyte-colony stimulating factor (G-CSF) has proved to be a successful therapy for some patients with Crohn's disease. Given the known ability of G-CSF to exert anti-T helper 1 effects and to induce interleukin (IL)-10-secreting regulatory T cells, we studied whether clinical benefit from G-CSF therapy in active Crohn's disease was associated with decreased inflammatory cytokine production and/or increased regulatory responses. Crohn's patients were treated with G-CSF (5 microg/kg/day subcutaneously) for 4 weeks and changes in cell phenotype, cytokine production and dendritic cell subsets were measured in the peripheral blood and colonic mucosal biopsies using flow cytometry, enzyme-linked immunosorbent assay and immunocytochemistry. Crohn's patients who achieved a clinical response or remission based on the decrease in the Crohn's disease activity index differed from non-responding patients in several important ways: at the end of treatment, responding patients had significantly more CD4(+) memory T cells producing IL-10 in the peripheral blood; they also had a greatly enhanced CD123(+) plasmacytoid dendritic cell infiltration of the lamina propria. Interferon-gamma production capacity was not changed significantly except in non-responders, where it increased. These data show that clinical benefit from G-CSF treatment in Crohn's disease is accompanied by significant induction of IL-10 secreting T cells as well as increases in plasmacytoid dendritic cells in the lamina propria of the inflamed gut mucosa.
AuthorsP J Mannon, F Leon, I J Fuss, B A Walter, M Begnami, M Quezado, Z Yang, C Yi, C Groden, J Friend, R L Hornung, M Brown, S Gurprasad, B Kelsall, W Strober
JournalClinical and experimental immunology (Clin Exp Immunol) Vol. 155 Issue 3 Pg. 447-56 (Mar 2009) ISSN: 1365-2249 [Electronic] England
PMID19094118 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural)
Chemical References
  • Cytokines
  • Recombinant Proteins
  • Interleukin-10
  • Granulocyte Colony-Stimulating Factor
Topics
  • Adult
  • Crohn Disease (drug therapy, immunology)
  • Cytokines (immunology)
  • Dendritic Cells (immunology)
  • Drug Administration Schedule
  • Female
  • Granulocyte Colony-Stimulating Factor (therapeutic use)
  • Humans
  • Immunohistochemistry
  • Immunophenotyping
  • Interleukin-10 (immunology)
  • Lymphocyte Activation (immunology)
  • Male
  • Mucous Membrane (immunology)
  • Pilot Projects
  • Recombinant Proteins
  • Statistics, Nonparametric
  • T-Lymphocytes, Regulatory (immunology)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: